170 related articles for article (PubMed ID: 34915108)
1. Use of
Pean de Ponfilly-Sotier M; Besson FL; Gomez L; Ottaviani S; Dieudé P; Pavy S; Mariette X; Seror R; Nocturne G
Joint Bone Spine; 2022 May; 89(3):105325. PubMed ID: 34915108
[TBL] [Abstract][Full Text] [Related]
2. Diagnosing polymyalgia rheumatica on
Yuge S; Nakatani K; Yoshino K; Koyama T
Ann Nucl Med; 2018 Oct; 32(8):573-577. PubMed ID: 29948622
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis.
van der Geest KSM; Treglia G; Glaudemans AWJM; Brouwer E; Jamar F; Slart RHJA; Gheysens O
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1876-1889. PubMed ID: 33372248
[TBL] [Abstract][Full Text] [Related]
4. On the use of
Giraud N; Verhoeven F; Wendling D; Prati C
Joint Bone Spine; 2022 Oct; 89(5):105377. PubMed ID: 35288266
[No Abstract] [Full Text] [Related]
5. Similarities and differences in fluorodeoxyglucose positron emission tomography/computed tomography findings in spondyloarthropathy, polymyalgia rheumatica and rheumatoid arthritis.
Yamashita H; Kubota K; Takahashi Y; Minamimoto R; Morooka M; Kaneko H; Kano T; Mimori A
Joint Bone Spine; 2013 Mar; 80(2):171-7. PubMed ID: 22749663
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities at three musculoskeletal sites on whole-body positron emission tomography/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity.
Owen CE; Poon AMT; Yang V; McMaster C; Lee ST; Liew DFL; Leung JL; Scott AM; Buchanan RRC
Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2461-2468. PubMed ID: 32090280
[TBL] [Abstract][Full Text] [Related]
7. Various forms of (18)F-FDG PET and PET/CT findings in patients with polymyalgia rheumatica.
Rehak Z; Vasina J; Nemec P; Fojtik Z; Koukalova R; Bortlicek Z; Rehakova D; Adam J; Vavrusova A; Adam Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):629-36. PubMed ID: 26006092
[TBL] [Abstract][Full Text] [Related]
8. Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: a controlled study.
Sondag M; Guillot X; Verhoeven F; Blagosklonov O; Prati C; Boulahdour H; Wendling D
Rheumatology (Oxford); 2016 Aug; 55(8):1452-7. PubMed ID: 27107429
[TBL] [Abstract][Full Text] [Related]
9. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in polymyalgia rheumatica: an observational study.
Casadepax-Soulet C; Benali K; Crestani B; Piekarski E; Mahida B; Ebstein E; Juge PA; Forien M; Dieudé P; Ottaviani S
Clin Exp Rheumatol; 2023 Jul; 41(7):1456-1462. PubMed ID: 36533978
[TBL] [Abstract][Full Text] [Related]
10.
Rehak Z; Sprlakova-Pukova A; Kazda T; Fojtik Z; Vargova L; Nemec P
Br J Radiol; 2017 Aug; 90(1076):20170198. PubMed ID: 28508663
[TBL] [Abstract][Full Text] [Related]
11. Differentiation between Polymyalgia Rheumatica (PMR) and Elderly-Onset Rheumatoid Arthritis Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Is Enthesitis a New Pathological Lesion in PMR?
Wakura D; Kotani T; Takeuchi T; Komori T; Yoshida S; Makino S; Hanafusa T
PLoS One; 2016; 11(7):e0158509. PubMed ID: 27384410
[TBL] [Abstract][Full Text] [Related]
12. Differences in fluorodeoxyglucose positron emission tomography/computed tomography findings between elderly onset rheumatoid arthritis and polymyalgia rheumatica.
Takahashi H; Yamashita H; Kubota K; Miyata Y; Okasaki M; Morooka M; Takahashi Y; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2015 Jul; 25(4):546-51. PubMed ID: 25401232
[TBL] [Abstract][Full Text] [Related]
13. Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment.
Palard-Novello X; Querellou S; Gouillou M; Saraux A; Marhadour T; Garrigues F; Abgral R; Salaün PY; Devauchelle-Pensec V
Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):773-9. PubMed ID: 26753600
[TBL] [Abstract][Full Text] [Related]
14. FDG PET/CT Imaging of Severe Polymyalgia Rheumatica.
Chen J; Wong VCK; Bui C; Mansberg R
Clin Nucl Med; 2023 Jul; 48(7):630-632. PubMed ID: 36928039
[TBL] [Abstract][Full Text] [Related]
15. The usefulness of 18F-FDG-PET/CT in detecting musculoskeletal and vascular involvement in patients with polymyalgia rheumatica receiving glucocorticoids.
Serrano-Combarro A; Prieto-Peña D; Martínez-Rodríguez I; Martínez-Amador N; Loricera J; Blanco R
Eur J Intern Med; 2024 Jun; 124():78-83. PubMed ID: 38302404
[TBL] [Abstract][Full Text] [Related]
16.
Horikoshi H; Nakanishi T; Tamura K; Kimura F; Itoh K
BMC Rheumatol; 2020; 4():21. PubMed ID: 32346670
[TBL] [Abstract][Full Text] [Related]
17. Polymyalgia Rheumatica: A syndrome with an enthesitic subset? Comment on: "Use of 18F FDG PET-CT to discriminate polymyalgia rheumatica and atypical spondylarthritis in clinical practice" by Marie Pean de Ponfilly-Sotier et al. Joint Bone Spine 2021;89:105325.
Falsetti P; Conticini E; Baldi C; Bardelli M; Gentileschi S; D'Alessandro R; Al Khayyat SG; Cantarini L; Frediani B
Joint Bone Spine; 2022 Oct; 89(5):105378. PubMed ID: 35288264
[No Abstract] [Full Text] [Related]
18. Role of
Slart RHJA; Nienhuis PH; Glaudemans AWJM; Brouwer E; Gheysens O; van der Geest KSM
J Nucl Med; 2023 Apr; 64(4):515-521. PubMed ID: 37011940
[TBL] [Abstract][Full Text] [Related]
19. Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis.
Yamashita H; Kubota K; Takahashi Y; Minaminoto R; Morooka M; Ito K; Kano T; Kaneko H; Takashima H; Mimoiri A
Mod Rheumatol; 2012 Sep; 22(5):705-11. PubMed ID: 22205118
[TBL] [Abstract][Full Text] [Related]
20. Assessing the feasibility of SUVindex (a metric derived from FDG PET/CT) for the diagnosis of polymyalgia rheumatica.
Sun S; Shao X; Liu X; Jiang W; Zhang L; Chen J; Wang Y; Xu T; Wu M
Clin Radiol; 2023 Oct; 78(10):737-745. PubMed ID: 37429761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
